134248388	134248388	CD	B-NP	O
|	|	NN	I-NP	O
ACH	ACH	NN	I-NP	O
|	|	NN	I-NP	O
00262479	00262479	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4565117	4565117	CD	B-NP	O
|	|	CC	I-NP	O
4/27/2006	4/27/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CONGESTIVE	CONGESTIVE	NNP	I-NP	I-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/18/2006	6/18/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/22/2006	6/22/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
BISCARI	BISCARI	NNP	B-NP	O
,	,	,	O	O
HUGO	HUGO	NNP	B-NP	O
MD	MD	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
GMS	GMS	NNP	B-NP	O
Ellpull	Ellpull	NNP	I-NP	O
Pkwy	Pkwy	NNP	I-NP	O
.	.	.	O	O

,	,	,	O	O
Belle	Belle	NNP	B-NP	O
Wood	Wood	NNP	I-NP	O
Eype	Eype	NNP	I-NP	O
,	,	,	O	O
Wyoming	Wyoming	NNP	B-NP	O
92815	92815	CD	I-NP	O
ATTENDING	ATTENDING	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Agustin	Agustin	NNP	I-NP	O
Hemerly	Hemerly	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
AFib	AFib	NN	B-NP	O
with	with	IN	B-PP	O
LVR	LVR	NN	B-NP	B-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

ASSOCIATE	ASSOCIATE	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
History	History	NN	B-NP	O
of	of	IN	B-PP	O
AFib	AFib	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
baseline	baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Dyspnea	Dyspnea	NN	B-NP	O
and	and	CC	I-NP	O
hypoxia	hypoxia	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
80-year-old	80-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
AFib	AFib	NN	B-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
and	and	CC	I-NP	O
CRI	CRI	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
who	who	WP	B-NP	O
recently	recently	RB	B-ADVP	O
discharged	discharge	VBD	B-VP	O
from	from	IN	B-PP	O
Trickrow	Trickrow	NNP	B-NP	O
University	University	NNP	I-NP	O
Of	Of	NNP	I-NP	O
Health	Health	NNP	I-NP	O
for	for	IN	B-PP	O
CHF	CHF	NNP	B-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
Class	Class	NN	I-NP	O
III	III	CD	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
at	at	IN	B-PP	O
about	about	IN	B-NP	O
20	20	CD	I-NP	O
feet	foot	NNS	I-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
the	the	DT	B-NP	O
CHF	CHF	NN	I-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liter	liter	NN	I-NP	O
home	home	NN	I-NP	O
O2	O2	NN	I-NP	O
and	and	CC	O	O
stated	state	VBD	B-VP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
for	for	IN	B-PP	O
about	about	IN	B-NP	O
a	a	DT	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
do	do	VB	I-VP	O
her	her	PRP$	B-NP	O
chores	chore	NNS	I-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
liter	liter	NN	I-NP	O
O2	O2	NN	I-NP	O
.	.	.	O	O

Had	Have	VBD	B-VP	O
been	be	VBN	I-VP	O
fully	fully	RB	B-ADVP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
VNA	VNA	NN	I-NP	O
and	and	CC	O	O
saw	see	VBD	B-VP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
stated	state	VBD	B-VP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
heart	heart	NN	B-NP	O
raising	raise	VBG	B-VP	O
and	and	CC	O	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
sleep	sleep	VB	I-VP	O
.	.	.	O	O

Overnight	Overnight	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
increased	increase	VBN	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
.	.	.	O	O

Daughter	Daughter	NN	B-NP	O
called	call	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
saw	see	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
to	to	TO	B-PP	O
3	3	CD	B-NP	O
liter	liter	NN	I-NP	O
and	and	CC	O	O
called	call	VBD	B-VP	O
VNA	VNA	NN	B-NP	B-protein
who	who	WP	B-NP	O
noted	note	VBD	B-VP	O
her	her	PRP$	B-NP	O
sat	sat	NN	I-NP	O
in	in	IN	B-PP	O
80s	80	NNS	B-NP	O
on	on	IN	B-PP	O
4	4	CD	B-NP	O
liter	liter	NN	I-NP	O
and	and	CC	O	O
told	tell	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
come	come	VB	I-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
stated	state	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
tried	try	VBN	I-VP	O
to	to	TO	I-VP	O
stick	stick	VB	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
low-sodium	low-sodium	JJ	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
taking	take	VBG	B-VP	O
the	the	DT	B-NP	O
home	home	NN	I-NP	O
medication	medication	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
double	double	JJ	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Sunday	Sunday	NNP	B-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
worsen	worsen	JJ	B-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
baseline	baseline	NN	B-NP	O
cough	cough	NN	I-NP	O
with	with	IN	B-PP	O
white	white	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
production	production	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
sating	sate	VBG	I-VP	O
at	at	IN	B-PP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
non-rebreather	non-rebreather	JJ	B-ADJP	O
.	.	.	O	O

Has	Has	JJ	B-NP	O
AFib	AFib	NN	I-NP	O
with	with	IN	B-PP	O
rate	rate	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
70	70	CD	I-NP	O
and	and	CC	I-NP	O
temperature	temperature	NN	I-NP	O
is	be	VBZ	B-VP	O
98	98	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
BUN	BUN	NN	I-NP	B-protein
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
IV	IV	CD	I-NP	O
x1	x1	CD	I-NP	O
and	and	CC	O	O
admitted	admit	VBN	B-VP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Atrial	Atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
COPD/asthma	COPD/asthma	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
baseline	baseline	NN	B-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
C-section	C-section	NN	I-NP	O
in	in	IN	B-PP	O
4/3	4/3	CD	B-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
hiatal	hiatal	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
,	,	,	O	O
PMR	PMR	NN	B-NP	B-protein
and	and	CC	O	O
colonic	colonic	JJ	B-NP	O
polyp	polyp	NN	I-NP	O
.	.	.	O	O

MEDICINE	MEDICINE	NNP	B-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
diltiazem	diltiazem	NN	B-NP	O
ER	ER	NN	I-NP	O
300	300	CD	I-NP	O
daily	daily	NN	I-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
250/50	250/50	CD	I-NP	O
b.i.d.	b.i.d.	NNP	I-NP	O
,	,	,	I-NP	O
Lasix	Lasix	NNP	I-NP	O
20	20	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	O
26	26	CD	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
16	16	CD	B-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Combivent	Combivent	NNP	B-NP	O
two	two	CD	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
fluvastatin	fluvastatin	NN	B-NP	O
20	20	CD	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
MVI	MVI	NN	B-NP	O
one	one	CD	I-NP	O
daily	daily	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NNP	B-NP	O
2.5	2.5	CD	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
1.5	1.5	CD	B-NP	O
Monday	Monday	NNP	B-NP	O
and	and	CC	O	O
Thursday	Thursday	NNP	B-NP	O
,	,	,	O	O
Avapro	Avapro	NNP	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	RB	B-ADVP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
,	,	,	O	O
Fosamax	Fosamax	NN	B-NP	B-protein
70	70	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
every	every	DT	B-NP	I-protein
week	week	NN	I-NP	I-protein
and	and	CC	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Halothane	Halothane	NN	B-NP	O
and	and	CC	I-NP	O
atenolol	atenolol	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Mother	Mother	NN	B-NP	O
and	and	CC	I-NP	O
sister	sister	NN	I-NP	O
with	with	IN	B-PP	O
heart	heart	NN	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
by	by	IN	B-PP	O
herself	herself	PRP	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
sign	sign	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	B-protein
96.5	96.5	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
78	78	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
110/70	110/70	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
20	20	CD	I-NP	O
and	and	CC	O	O
O2	O2	NN	B-NP	O
sating	sate	VBG	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
non-rebreather	non-rebreather	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
mild	mild	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
wearing	wear	VBG	B-VP	O
a	a	DT	B-NP	O
facemask	facemask	NN	I-NP	O
.	.	.	O	O

JVPs	JVP	NNS	B-NP	B-protein
at	at	IN	B-PP	O
10	10	CD	B-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
:	:	:	O	O
Bilateral	Bilateral	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
one-half	one-half	RB	B-ADVP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
lungs	lung	NNS	I-NP	O
.	.	.	O	O

Decreased	Decrease	VBN	B-NP	O
lung	lung	NN	I-NP	B-protein
sound	sound	NN	I-NP	I-protein
at	at	IN	B-PP	I-protein
bases	base	NNS	B-NP	I-protein
.	.	.	O	O

Cardiac	Cardiac	JJ	B-ADVP	O
:	:	:	O	O
Irregularly	Irregularly	RB	B-NP	O
irregular	irregular	JJ	I-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
2/6	2/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
Soft	Soft	JJ	B-ADJP	O
,	,	,	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
nondistended	nondistended	JJ	I-ADJP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
and	and	CC	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
Alert	Alert	NNP	B-NP	O
and	and	CC	O	O
oriented	orient	VBN	B-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

Nonfocal	Nonfocal	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
significant	significant	JJ	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
2.8	2.8	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.5	4.5	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
34.3	34.3	CD	I-NP	I-protein
and	and	CC	O	O
INR	INR	NN	B-NP	B-protein
2.8	2.8	CD	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
LFTs	LFT	NNS	I-NP	O
panels	panel	NNS	B-NP	O
are	be	VBP	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limit	limit	NN	I-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
559	559	CD	B-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
99	99	CD	B-NP	O
,	,	,	O	O
MB	MB	NN	B-NP	B-protein
2.5	2.5	CD	I-NP	I-protein
,	,	,	O	O
troponin	troponin	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
,	,	,	O	O
dig	dig	NN	B-NP	O
2.4	2.4	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
elevated	elevate	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
UA	UA	NN	I-NP	O
is	be	VBZ	B-VP	O
significant	significant	JJ	B-NP	O
2	2	CD	I-NP	O
+	+	SYM	I-NP	O
blood	blood	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
to	to	TO	I-NP	O
4	4	CD	I-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
squames	squame	NNS	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
shows	show	VBZ	B-VP	O
dig	dig	NN	B-NP	O
effect	effect	NN	I-NP	O
,	,	,	O	O
AFib	AFib	NN	B-NP	O
,	,	,	O	O
rate	rate	NN	B-NP	O
of	of	IN	B-PP	O
61	61	CD	B-NP	O
,	,	,	O	O
T-wave	T-wave	JJ	B-NP	O
inversion	inversion	NN	I-NP	O
in	in	IN	B-PP	O
I	I	PRP	B-NP	O
,	,	,	O	O
II	II	CD	B-NP	O
,	,	,	O	O
aVL	aVL	NN	B-NP	O
,	,	,	O	O
aVF	aVF	NN	B-NP	O
,	,	,	O	O
V6	V6	NN	B-NP	B-protein
otherwise	otherwise	RB	B-ADJP	O
uncharged	uncharged	JJ	I-ADJP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	JJ	I-NP	O
bilateral	bilateral	JJ	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
right	right	JJ	B-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

TTE	TTE	NN	B-NP	O
on	on	IN	B-PP	O
5/22	5/22	CD	B-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
LV	LV	NN	B-NP	O
size	size	NN	I-NP	O
,	,	,	O	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
RV	RV	NN	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
LAE	LAE	NN	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	B-protein
MR	MR	NN	I-NP	I-protein
,	,	,	O	O
TR	TR	NN	B-NP	B-protein
,	,	,	O	O
hypodynamic	hypodynamic	JJ	B-NP	O
heart	heart	NN	I-NP	O
,	,	,	O	O
PA	PA	NN	B-NP	O
systolic	systolic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
at	at	IN	B-PP	O
38	38	CD	B-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
AND	AND	CC	I-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
80	80	CD	I-NP	O
years	year	NNS	I-NP	O
old	old	JJ	B-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
AFib	AFib	NN	B-NP	O
and	and	CC	I-NP	O
CHF	CHF	NN	I-NP	B-protein
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
COPD	COPD	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	O
w	w	NN	I-NP	O
low	low	JJ	I-NP	O
dose	dose	NN	I-NP	O
lasix	lasix	NN	I-NP	O
of	of	IN	B-PP	O
20mg	20mg	NN	B-NP	O
now	now	RB	B-ADVP	O
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
in	in	IN	B-PP	O
a	a	DT	B-NP	O
setting	setting	NN	I-NP	O
with	with	IN	B-PP	O
suspected	suspect	VBN	B-NP	O
AFib	AFib	NN	I-NP	O
with	with	IN	B-PP	O
LVR	LVR	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
low	low	JJ	B-NP	O
flow	flow	NN	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
volume	volume	NN	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
Ischemia	Ischemia	NNP	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
with	with	IN	B-PP	O
serial	serial	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
betablocker	betablocker	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
short	short	JJ	B-NP	O
acting	act	VBG	I-NP	O
diltiazem	diltiazem	NN	I-NP	O
and	and	CC	I-NP	O
statin	statin	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
not	not	RB	I-VP	O
initiated	initiate	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
short-dose	short-dose	JJ	B-NP	O
beta-blockade	beta-blockade	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
that	that	IN	B-ADVP	O
reasonably	reasonably	RB	B-ADVP	O
well	well	RB	I-ADVP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
to	to	TO	B-PP	O
40s	40s	CD	B-NP	O
.	.	.	O	O

Decision	Decision	NN	B-NP	O
was	be	VBD	B-VP	O
reached	reach	VBN	I-VP	O
to	to	TO	B-VP	O
defer	defer	VB	I-VP	O
starting	start	VBG	B-NP	O
betablockade	betablockade	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP	B-NP	O
until	until	IN	B-PP	O
her	her	PRP$	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
BB	BB	NN	I-NP	I-protein
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
volume	volume	NN	B-NP	O
over	over	IN	B-PP	O
loaded	load	VBN	B-VP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
with	with	IN	B-PP	O
BNP	BNP	NN	B-NP	B-protein
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
500	500	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
hypodynamic	hypodynamic	JJ	B-NP	O
heart	heart	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diuresing	diurese	VBG	I-VP	O
initially	initially	RB	B-ADVP	O
with	with	IN	B-PP	O
80	80	CD	B-NP	O
IV	IV	CD	I-NP	O
Lasix	Lasix	NN	I-NP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
increased	increase	VBD	I-VP	O
to	to	TO	B-PP	O
120	120	CD	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
slowly	slowly	RB	B-ADVP	O
at	at	IN	B-PP	O
about	about	RB	B-NP	O
500	500	CD	I-NP	O
mL	mL	NN	I-NP	O
everyday	everyday	NN	I-NP	O
.	.	.	O	O

Ultimately	Ultimately	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
over	over	RP	B-PRT	O
to	to	TO	B-PP	O
160	160	CD	B-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
with	with	IN	B-PP	O
very	very	RB	B-NP	O
good	good	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
,	,	,	O	O
prompting	prompt	VBG	B-VP	O
decreasing	decrease	VBG	I-VP	O
her	her	PRP$	B-NP	O
Lasix	Lasix	NNP	I-NP	O
back	back	RB	B-ADVP	O
down	down	RB	I-ADVP	O
to	to	TO	B-PP	O
120	120	CD	B-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
dose	dose	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
followup	followup	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
for	for	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
trial	trial	NN	I-NP	O
and	and	CC	O	O
make	make	VB	B-VP	O
sure	sure	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
is	be	VBZ	B-VP	O
trending	trend	VBG	I-VP	O
down	down	RP	B-PRT	O
.	.	.	O	O

We	We	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
want	want	VB	I-VP	O
to	to	TO	B-PP	O
over	over	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
volume	volume	NN	I-NP	O
dependence	dependence	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
especially	especially	RB	B-ADVP	O
as	as	IN	B-SBAR	O
we	we	PRP	B-NP	O
suspect	suspect	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
is	be	VBZ	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
really	really	RB	B-ADVP	O
significant	significant	JJ	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
shows	show	VBZ	B-VP	O
slightly	slightly	RB	I-VP	O
improving	improve	VBG	I-VP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
repeat	repeat	VB	I-VP	O
lytes	lyte	NNS	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
very	very	RB	B-ADVP	O
closely	closely	RB	I-ADVP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
afib	afib	JJ	B-NP	O
w	w	NN	I-NP	O
RVR	RVR	NN	I-NP	O
initially	initially	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
diltiazem	diltiazem	NN	B-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
hold	hold	VBP	B-VP	O
her	her	PRP$	B-NP	O
dig	dig	NN	I-NP	O
initially	initially	RB	B-ADVP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
to	to	TO	B-PP	O
2.4	2.4	CD	B-NP	O
eventually	eventually	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
dig	dig	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
at	at	IN	B-PP	O
0.125	0.125	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-PP	O
every	every	DT	B-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
dig	dig	NN	I-NP	O
level	level	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
dig	dig	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
particular	particular	JJ	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
started	start	VBD	B-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
short	short	JJ	B-NP	O
acting	act	VBG	I-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
with	with	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
at	at	IN	B-PP	O
6.25	6.25	CD	B-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
6.25	6.25	CD	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
though	though	IN	B-SBAR	O
had	have	VBD	O	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
.	.	.	O	O

BB	BB	NN	B-NP	O
was	be	VBD	B-VP	O
d/c	d/c	NN	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
despite	despite	IN	B-PP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
CHF	CHF	NN	B-NP	B-protein
and	and	CC	I-NP	O
COPD	COPD	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
nebs	neb	NNS	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
Advair	Advair	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
4	4	CD	B-NP	O
liter	liter	NN	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
self-weaned	self-weaned	JJ	B-ADJP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
liter	liter	NN	I-NP	O
as	as	IN	B-PP	O
possible	possible	JJ	B-ADJP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
baseline	baseline	NN	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
for	for	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Has	Has	NNP	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Avapro	Avapro	NNP	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
initially	initially	RB	B-ADVP	O
.	.	.	O	O

Suspect	Suspect	VB	B-VP	O
that	that	DT	B-NP	O
her	her	PRP	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
is	be	VBZ	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	O
flow	flow	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
AFib	AFib	NN	B-NP	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
and	and	CC	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
actually	actually	RB	B-ADVP	O
improved	improve	VBD	B-VP	O
slightly	slightly	RB	B-ADVP	O
upon	upon	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
bumped	bump	VBD	B-VP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
slightly	slightly	RB	B-ADVP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
high-dose	high-dose	JJ	B-NP	O
Lasix	Lasix	NNP	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Lasix	Lasix	NNP	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
120	120	CD	B-NP	O
b.i.d.	b.i.d.	JJ	I-NP	O
p.o.	p.o.	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
checked	check	VBN	I-VP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
some	some	DT	B-NP	O
sputum	sputum	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
flora	flora	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
culture	culture	NN	I-NP	O
and	and	CC	O	O
urine	urine	NN	B-NP	O
culture	culture	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
PA	PA	NNP	I-NP	O
and	and	CC	O	O
lateral	lateral	JJ	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
consolidation	consolidation	NN	B-NP	O
or	or	CC	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
low-salt	low-salt	JJ	I-NP	O
ADA	ADA	NN	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
K	K	NN	B-NP	O
and	and	CC	I-NP	O
mag	mag	NN	I-NP	O
repletion	repletion	NN	I-NP	O
.	.	.	O	O

Prophylasix	Prophylasix	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
anticoagulated	anticoagulate	VBN	I-VP	O
with	with	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
PPI	PPI	NN	I-NP	B-protein
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
cardiologist	cardiologist	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
appointment	appointment	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Kohli	Kohli	NNP	I-NP	O
on	on	IN	B-PP	O
3/24/2006	3/24/2006	CD	B-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Mccarl	Mccarl	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
on	on	IN	B-PP	O
2/25/2006	2/25/2006	CD	B-NP	O
at	at	IN	B-PP	O
8	8	CD	B-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATION	MEDICATION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
DuoNeb	DuoNeb	NNP	B-NP	O
3/0	3/0	CD	I-NP	O
.5	.5	CD	I-NP	O
neb	neb	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
Fosamax	Fosamax	NN	B-NP	B-protein
70	70	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	I-NP	I-protein
every	every	DT	B-NP	I-protein
week	week	NN	I-NP	I-protein
,	,	,	O	O
Tessalon	Tessalon	NNP	B-NP	O
Perles	Perles	NNP	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
every	every	DT	B-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
diltiazem	diltiazem	NN	B-NP	O
extended	extend	VBD	B-VP	O
release	release	NN	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
250/50	250/50	CD	I-NP	O
one	one	CD	I-NP	O
puff	puff	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
26	26	CD	B-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
16	16	CD	B-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
lovastatin	lovastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
omeprazole	omeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-3643732	4-3643732	CD	B-NP	O
VFFocus	VFFocus	NN	I-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
George	George	NNP	B-NP	O
Ratkowski	Ratkowski	NNP	I-NP	O
MD	MD	NNP	I-NP	O
Proc	Proc	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Cra	Cra	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
OCASIO	OCASIO	NNP	B-NP	O
,	,	,	O	O
QUINCY	QUINCY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BROXTON	BROXTON	NNP	B-NP	O
,	,	,	O	O
LOREN	LOREN	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
0971224	0971224	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/22/06	10/22/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/22/06	10/22/06	CD	B-NP	O

